Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs …
to estimate the association of treatment success and death with the use of individual drugs …
Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
Objective: To compare the effectiveness of second line injectables containing shorter
(duration 9–12 months) and longer treatment regimens (LTR, duration≥ 20 months) among …
(duration 9–12 months) and longer treatment regimens (LTR, duration≥ 20 months) among …
Frequency and factors associated with adverse events among multi-drug resistant tuberculosis patients in Pakistan: A retrospective study
Background Treatment of multi-drug resistant tuberculosis (MDR-TB) for a prolonged period
with comparatively less effective and more toxic second-line anti-TB drugs is associated with …
with comparatively less effective and more toxic second-line anti-TB drugs is associated with …
An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis
ML Bastos, Z Lan, D Menzies - European Respiratory …, 2017 - publications.ersnet.org
This systematic review aimed to update the current evidence for multidrug-resistant
tuberculosis (MDR-TB) treatment. We searched for studies that reported treatment …
tuberculosis (MDR-TB) treatment. We searched for studies that reported treatment …
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
Background Treatment of multidrug-resistant tuberculosis requires long-term therapy with a
combination of multiple second-line drugs. These drugs are associated with numerous …
combination of multiple second-line drugs. These drugs are associated with numerous …
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised …
F von Groote-Bidlingmaier, R Patientia… - The Lancet …, 2019 - thelancet.com
Background Delamanid is one of two recently approved drugs for the treatment of multidrug-
resistant tuberculosis. We aimed to evaluate the safety and efficacy of delamanid in the first …
resistant tuberculosis. We aimed to evaluate the safety and efficacy of delamanid in the first …
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
Background The worldwide emergence of multidrug-resistant tuberculosis (MDR-TB) and
extensively drug-resistant tuberculosis (XDR-TB) has posed additional challenges for global …
extensively drug-resistant tuberculosis (XDR-TB) has posed additional challenges for global …
Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis
Little is known about the impact of comorbidities on multidrug resistant (MDR) and
extensively drug resistant (XDR) tuberculosis (TB) treatment outcomes. We aimed to …
extensively drug resistant (XDR) tuberculosis (TB) treatment outcomes. We aimed to …
[HTML][HTML] The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review …
Objectives We aimed to evaluate the effect of undernutrition on sputum culture conversion
and treatment outcomes among people with multidrug-resistant tuberculosis (MDR-TB) …
and treatment outcomes among people with multidrug-resistant tuberculosis (MDR-TB) …
Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences
Background Despite that confirmative diagnosis of pulmonary drug-sensitive tuberculosis
(DS-TB) and multidrug resistant tuberculosis (MDR-TB) is determined by microbiological …
(DS-TB) and multidrug resistant tuberculosis (MDR-TB) is determined by microbiological …